Research and evidence
Built with people.
Tested in practice.
Osteoporosis Options grew from the iFraP research programme: a rigorous, collaborative effort to make treatment conversations more person-centred and easier to understand.
How we got here
Three phases of careful development
The Fracture Liaison Service consultation tool and consultation-skills training were developed and tested through the iFraP study.
Co-designing the resources with patients, carers and clinicians.
Initial testing and refinement of the resources at one site.
Testing the complete intervention across four services in England.
patients took part in a randomised controlled trial across four Fracture Liaison Services.
Main trial findings
Patients reported better conversations and clearer decisions.
Easier decision-making about osteoporosis medicines
Increased person-centred care
Greater satisfaction with written and verbal information
More accurate perceptions of fracture risk
A clearer understanding of the need for treatment
Continuing the work
Widening access and impact
Linked studies are helping adapt the resources for primary care and improve how bone-health information is communicated.
Pharmacist-led osteoporosis review
Exploring the role, consultation model and training needs of practice-based pharmacists.
Understanding bone density scans
Improving how patients and professionals understand and communicate DXA results.
Osteoporosis in primary care
Mapping current practice and training needs through a national survey and interviews.
Other resources
Evidence you can use
We partnered with the Royal Osteoporosis Society to create ERO hub: a reviewed library of evidence-based osteoporosis resources for professionals and the public.
Scientific publications
Read the research
Why we developed the resources+
Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan.
Public priorities for osteoporosis and fracture research: results from a focus group study.
Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review.
Evaluation of quality and readability of online patient information on osteoporosis drug treatment.
How we developed the resources+
Testing and linked studies+
A person-centred consultation intervention to improve shared decision-making about osteoporosis medicines: trial protocol.
A person-centred primary care pharmacist-led osteoporosis review for optimising medicines (PHORM).
Osteoporosis care in primary care settings: a national UK e-survey.
Getting to what matters for people with osteoporosis in clinical consultations.